Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
What fecal calprotectin test means
Calprotectin is a calcium-binding protein that floods your intestinal tract when neutrophils (a type of white blood cell) detect threats. Think of neutrophils as your gut's first responders. When they sense bacteria, damaged tissue, or other inflammatory triggers, they release calprotectin along with other defensive compounds.
This protein survives the digestive journey intact when samples are handled promptly, making it a useful window into what's happening along your intestinal tract. Because calprotectin degrades at room temperature over several days, laboratories recommend refrigerating samples until delivery to preserve accuracy.
The fecal calprotectin test measures calprotectin concentration in micrograms per gram of stool (mcg/g). Higher concentrations indicate more neutrophil activity, which typically means more inflammation. Unlike systemic inflammation markers in blood, calprotectin reflects localized gut inflammation specifically.
This test became valuable because it bridges a diagnostic gap. Blood tests can miss intestinal inflammation, especially when it's mild or localized. Invasive procedures like colonoscopy provide direct visualization but aren't practical for routine monitoring. Calprotectin offers a middle ground: specific, non-invasive, and repeatable.
The test is particularly useful for distinguishing inflammatory conditions like inflammatory bowel disease from functional disorders like irritable bowel syndrome. This distinction matters because treatment approaches differ significantly between these categories.
How to interpret fecal calprotectin test
Most laboratories use 50 mcg/g as the upper limit of normal, though some use 60 mcg/g. Results below this threshold suggest minimal intestinal inflammation. Results above this level indicate elevated neutrophil activity in your gut.
The interpretation framework follows three general zones. Levels below 50 mcg/g typically indicate low inflammation risk. Levels between 50-200 mcg/g suggest mild to moderate inflammation that warrants investigation. Levels above 200 mcg/g often indicate significant inflammatory activity requiring medical evaluation.
However, numbers alone don't tell the complete story. A result of 75 mcg/g in someone with severe abdominal pain carries different implications than the same level in someone feeling perfectly well. Symptoms, medical history, and other test results create the complete picture.
Trending matters more than single measurements. Calprotectin levels can fluctuate based on diet, stress, medications, and minor infections. A pattern of consistently elevated results carries more weight than one isolated high reading.
Consider the clinical context carefully. Someone with known inflammatory bowel disease might use calprotectin to monitor treatment response, where declining levels indicate improvement. Someone with unexplained digestive symptoms might use it to determine whether inflammation is contributing to their issues.
What can influence fecal calprotectin test
Medications significantly impact calprotectin levels. NSAIDs (non-steroidal anti-inflammatory drugs) like ibuprofen can raise your levels and reduce the test's specificity. Proton pump inhibitors (PPIs) for acid reflux may also elevate results by altering gut bacteria and intestinal permeability.
Recent infections can leave lingering inflammatory signatures. Gastroenteritis from food poisoning or viral infections can keep calprotectin elevated after symptoms resolve, and minor bacterial overgrowth episodes can temporarily raise levels.
Dietary and lifestyle factors can create short-term fluctuations. Heavy alcohol consumption may affect test accuracy alongside medications like NSAIDs and PPIs that influence gut barrier function.
Physical stress affects gut inflammation directly. Intense exercise, lack of sleep, and psychological stress all influence intestinal barrier function and immune activity. Age also plays a role, with calprotectin levels naturally increasing in older adults due to age-related changes in gut barrier function.
Sample collection timing matters. Diarrheal stools often show higher concentrations due to reduced water reabsorption, while constipated stools might show lower levels due to longer transit times.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Related context that changes the picture
Lactoferrin is another neutrophil protein measured in stool that often correlates with calprotectin. When both markers are elevated together, it strengthens the evidence for active intestinal inflammation. Discordant results might suggest different inflammatory processes or sample collection issues.
Blood inflammatory markers provide additional context. Elevated C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) alongside high calprotectin suggests systemic inflammation extending beyond the gut. Normal blood markers with elevated calprotectin point to localized intestinal inflammation.
Microbiome testing can reveal connections. Bacterial imbalances in the gut may influence calprotectin levels, and shifts in gut flora have been linked to intestinal inflammation in various settings.
Take action on your digestive health
Understanding your fecal calprotectin levels is just the beginning. This marker reveals whether inflammation is affecting your gut, but the complete picture requires additional context about your overall digestive and metabolic health.
Superpower's comprehensive testing approach includes digestive health markers alongside metabolic, hormonal, and inflammatory indicators that influence gut function. This broader view helps identify root causes of intestinal inflammation and guides more targeted interventions.
Explore Superpower's testing options to get the complete picture of your digestive health and take control of your gut inflammation.
Frequently Asked Questions
References
- Huynh D, Rubtsov D, Basu D, Khaing MM (2024). The Diagnostic Utility of Biochemical Markers and Intestinal Ultrasound Compared with Endoscopy in Patients with Crohn's Disease and Ulcerative Colitis: A Systemic Review and Meta-Analysis. *Journal of clinical medicine*, *13*(11). https://doi.org/10.3390/jcm13113030
- Dajti E, Frazzoni L, Iascone V, Secco M, Vestito A, Fuccio L, Eusebi LH, Fusaroli P, Rizzello F, Calabrese C, Gionchetti P, Bazzoli F, Zagari RM (2023). Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults. *Alimentary pharmacology & therapeutics*, *58*(11-12), 1120-1131. https://doi.org/10.1111/apt.17754
- Rendek Z, Falk M, Grodzinsky E, Kechagias S, Hjortswang H (2023). Diagnostic value of fecal calprotectin in primary care patients with gastrointestinal symptoms: A retrospective Swedish cohort study. *JGH open : an open access journal of gastroenterology and hepatology*, *7*(10), 708-716. https://doi.org/10.1002/jgh3.12972
- Haisma SM, van Rheenen PF, Wagenmakers L, Muller Kobold A (2020). Calprotectin instability may lead to undertreatment in children with IBD. *Archives of disease in childhood*, *105*(10), 996-998. https://doi.org/10.1136/archdischild-2018-316584
- Bromke MA, Neubauer K, Kempiński R, Krzystek-Korpacka M (2021). Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis. *Journal of clinical medicine*, *10*(10). https://doi.org/10.3390/jcm10102203
- Traini I, Chan SY, Menzies J, Hughes J, Coffey MJ, McKay IR, Ooi CY, Leach ST, Krishnan U (2024). Intestinal dysbiosis and inflammation in children with repaired esophageal atresia. *Journal of pediatric gastroenterology and nutrition*, *78*(1), 43-51. https://doi.org/10.1002/jpn3.12053
- Thorsvik S, Damås JK, Granlund AV, Flo TH, Bergh K, Østvik AE, Sandvik AK (2017). Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease. *Journal of gastroenterology and hepatology*, *32*(1), 128-135. https://doi.org/10.1111/jgh.13598
- Stríz I, Trebichavský I (2004). Calprotectin - a pleiotropic molecule in acute and chronic inflammation. *Physiological research*, *53*(3), 245-53. https://pubmed.ncbi.nlm.nih.gov/15209531/
- Ross FA, Park JH, Mansouri D, Combet E, Horgan PG, McMillan DC, Roxburgh CSD (2022). The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis. *BMC gastroenterology*, *22*(1), 176. https://doi.org/10.1186/s12876-022-02220-1














